Roquette completes the acquisition of Qualicaps and reinforces its global position in the pharmaceutical industry
This strategic investment creates a stronger leader, with an expanded global footprint, as well as an enriched offering of oral dosage solutions
23 Oct 2023
Roquette, a company specializing in plant-based ingredients and pharmaceutical excipients, recently announced the completion of the acquisition of Qualicaps from the Mitsubishi Chemical Group.
Qualicaps is a manufacturer of hard capsules and pharmaceutical-related equipment, and is the third largest producer of hard capsules for oral dosage solutions. The company relies on high-quality products and a strong innovation pipeline.
Roquette is a family-owned maker of plant-based ingredients and a leading provider of pharmaceutical excipients. The company currently operates in more than 100 countries, and, with this acquisition, will employ around 10,000 people worldwide.
Expanding Roquette’s global footprint in the pharma business
This strategic investment offers Roquette the ability to expand the global footprint of its pharmaceutical business, as well as enrich its offerings of oral dosage solutions. Roquette’s knowledge and expertise in the development of pharmaceutical excipients will be further enhanced by Qualicaps’ expertise in capsules, as well as by their assets and infrastructure.
The newly combined business will offer the most diverse solutions with a full range of hard and soft capsules, fillers and binders, disintegrants and other solutions.
Common commitments and ambition
Roquette and Qualicaps will continue to offer high-quality products and services, and will provide technical capabilities through a single point of contact for its expanded offering. This will provide customers with an improved level of service and access to a stronger technical base for the development of future solutions and innovations.
Pierre Courduroux, CEO of Roquette, said, “This acquisition is a key milestone in our journey to reinforce our global leadership in pharmaceutical solutions and to consolidate our position in nutrition and health markets. Thanks to our combined workforce, we will continue to grow our business through collaboration with our customers and to bring our expertise and innovation to all stages of pharmaceutical development.”
Seiichiro Matsumura, CEO of Qualicaps, said, “Today marks a pivotal moment in Qualicaps' journey. Partnering with Roquette, a renowned global leader in pharmaceutical excipients, marks the beginning of a transformative era of growth and innovation for our company. Together, we are poised to lead innovation, enrich our product portfolio, and deliver greater value to our global customer and stakeholder base. This partnership is an important step forward in our commitment to advancing healthcare solutions worldwide.”